High-Dose Chemotherapy in High-Risk Primary Breast Cancer

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Oncology Research and Treatment

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000055220PMID 12006761
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications.

  2001cited by this paper
• High-dose chemotherapy for high-risk primary breast cancer: an on-site review of the Bezwoda study.

  2000cited by this paper
• Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.

  2000cited by this paper
• Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial

  2000cited by this paper
• Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.

  2000cited by this paper
• Re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.

  2000cited by this paper
• Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22.

  1997cited by this paper
• High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.

  1995cited by this paper
• Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma.

  1994cited by this paper
• High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

  1993cited by this paper
• Bone marrow autotransplantation for solid tumors--prospects.

  1989cited by this paper
• Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.

  1989cited by this paper
• Dose: a critical factor in cancer chemotherapy.

  1980cited by this paper
• Primary breast cancer.

  1969cited by this paper

• Early diagnosis of sarcoidosis.

  2003cites this paper
• Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine

  2003cites this paper
• Disseminating health care innovation.

  2003cites this paper
• Bone marrow and peripheral blood hematopoietic stem cell transplantation: focus on autografting.

  2000cites this paper
• High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer.

  2000cites this paper
• High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Breast Cancer

  2000cites this paper
• Methodological arguments for the necessity of randomized trials in high-dose chemotherapy for breast cancer

  1999influential citation
• The Emperor’s New Clothes and the Nobel Frauds

  year unknowncites this paper